Patients were randomly assigned to receive GS ( oral S-@ @mg/m ( @ ) daily on days @-@ every @weeks and gemcitabine @,@ mg/m ( @ ) on days @ and @ ) or gemcitabine ( @,@ mg/m ( @ ) on days @ , @ , and @ every @weeks ) .